Upregulation of SRPK1 drives phosphorylation and nuclear translocation of the splicing factor SRSF1, which enhances splicing of the pro‐angiogenic VEGF165 isoform in Wilms Tumour [58], melanoma [73] and prostate cancer [47]. Here, SRPK1 is linked to prostate carcinoma.